Brandywine Realty Trust (BDN) Reports In-Line Q3 FFO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/1/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts BDN Hot Sheet
Price: $2.98 -1.32%
Financial Fact:
Net loss attributable to non-controlling interests: -58K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Financial Fact:
Net loss attributable to non-controlling interests: -58K
Today's EPS Names:
OPY, BNCC, ZVOI, More
Join SI Premium – FREE
Brandywine Realty Trust (NYSE: BDN) reported Q3 FFO of $0.39, in-line with the analyst estimate of $0.39. Revenue for the quarter came in at $140.38 million versus the consensus estimate of $143.54 million.
Sees FY2012 FFO of $1.33-1.36, versus prior guidance of $1.32-1.36 and the consensus of $1.34.
Also sees FY20123 FFO of $1.38-1.46, versus the consensus of $1.40.
For earnings history and earnings-related data on Brandywine Realty Trust (BDN) click here.
Sees FY2012 FFO of $1.33-1.36, versus prior guidance of $1.32-1.36 and the consensus of $1.34.
Also sees FY20123 FFO of $1.38-1.46, versus the consensus of $1.40.
For earnings history and earnings-related data on Brandywine Realty Trust (BDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercose ISI downgrades Reddit, says monetization may not offset traffic weakness
- enVVeno Medical (NVNO) Misses Q3 EPS by 302c
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
